Amanote Research

Amanote Research

    RegisterSign In

FDA Will Increase Postmarketing Surveillance of Drugs

BMJ
doi 10.1136/bmj.329.7476.1203-a
Full Text
Open PDF
Abstract

Available in full text

Date

November 20, 2004

Authors
J. H. Tanne
Publisher

BMJ


Related search

Postmarketing Surveillance of Adverse Drug Reactions

BMJ
1984English

Postmarketing Surveillance Study of Permethrin Creme Rinse.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1992English

FDA Approval of New Drugs

JAMA - Journal of the American Medical Association
Medicine
2014English

FDA Approval of Obesity Drugs

JAMA - Journal of the American Medical Association
Medicine
2012English

Postmarketing Surveillance of the Safety and Effectiveness of Etanercept in Japan

Journal of Rheumatology
RheumatologyAllergyImmunology
2009English

Development, Production, and Postmarketing Surveillance of Hepatitis a Vaccines in China

Journal of Epidemiology
MedicineEpidemiology
2014English

FDA Warning to Manufacturers of AIDS Drugs

Western Journal of Medicine
2001English

The FDA Warning on Anesthesia Drugs

Anesthesia Progress
AnesthesiologyPain Medicine
2017English

Repurposing FDA-approved Drugs for Anti-Aging Therapies

Biogerontology
AgingGerontologyGeriatrics
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy